Bridgeway Capital Management’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $259K | Hold |
67,900
|
|
||||
2025
Q1 | $179K | Sell |
67,900
-34,400
|
|
||||
2024
Q4 | $362K | Sell |
102,300
-37,600
|
|
||||
2024
Q3 | $638K | Sell |
139,900
-49,100
|
|
||||
2024
Q2 | $822K | Hold |
189,000
|
|
||||
2024
Q1 | $949K | Buy |
189,000
+45,000
|
|
||||
2023
Q4 | $903K | Hold |
144,000
|
|
||||
2023
Q3 | $1.03M | Hold |
144,000
|
|
||||
2023
Q2 | $1.47M | Sell |
144,000
-48,200
|
|
||||
2023
Q1 | $1.74M | Hold |
192,200
|
|
||||
2022
Q4 | $1.38M | Buy |
192,200
+60,000
|
|
||||
2022
Q3 | $862K | Hold |
132,200
|
|
||||
2022
Q2 | $637K | Hold |
132,200
|
|
||||
2022
Q1 | $751K | Hold |
132,200
|
|
||||
2021
Q4 | $664K | Hold |
132,200
|
|
||||
2021
Q3 | $879K | Buy |
132,200
+30,000
|
|
||||
2021
Q2 | $624K | Sell |
102,200
-500
|
|
||||
2021
Q1 | $683K | Buy |
+102,700
|
|
||||
2020
Q4 | – | Sell |
-39,200
|
|
||||
2020
Q3 | $292K | Hold |
39,200
|
|
||||
2020
Q2 | $289K | Sell |
39,200
-25,000
|
|
||||
2020
Q1 | $475K | Hold |
64,200
|
|
||||
2019
Q4 | $363K | Buy |
64,200
+2,700
|
|
||||
2019
Q3 | $364K | Hold |
61,500
|
|
||||
2019
Q2 | $196K | Sell |
61,500
-2,800
|
|
||||
2019
Q1 | $193K | Buy |
64,300
+50,000
|
|
||||
2018
Q4 | $54K | Sell |
14,300
-55,200
|
|
||||
2018
Q3 | $408K | Hold |
69,500
|
|
||||
2018
Q2 | $393K | Hold |
69,500
|
|
||||
2018
Q1 | $862K | Buy |
+69,500
|
|